Scientists see these discussions as a key piece of value-based care, improving patient outcomes without increasing costs, according to an analysis published in Clinical Imaging.
A reversal in COVID telehealth reimbursement could further demoralize a medical specialty that has arguably carried more than its own weight during the public health crisis.